scholarly journals Evidence of delayed ?-cell destruction in Type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies

Diabetologia ◽  
1984 ◽  
Vol 27 (4) ◽  
pp. 421-426 ◽  
Author(s):  
A. Mustonen ◽  
M. Knip ◽  
N. -P. Huttunen ◽  
R. Puukka ◽  
M. -L. K��r ◽  
...  
Diabetologia ◽  
1985 ◽  
Vol 28 (12) ◽  
pp. 875-880 ◽  
Author(s):  
B. Marner ◽  
T. Agner ◽  
C. Binder ◽  
�. Lernmark ◽  
J. Nerup ◽  
...  

1987 ◽  
Vol 13 (4) ◽  
pp. 381-385 ◽  
Author(s):  
Paula M. Hale ◽  
Timothy J. Pasquarello ◽  
Pnina Vardi

The discovery of anti-islet cell antibodies (ICAb's) in the sera of individuals with insulin- dependent diabetes (IDDM) was a significant milestone in the history of diabetes research. ICAb's have been found in the sera of 60%-85% of new-onset diabetic patients. It has been suggested that ICAb's play a role in the destruction of beta cells possibly by complement- mediated beta cell lysis, or by acting as mediators in antibody- dependent cell-mediated cytotoxicity. ICAb's have been shown to be markers of ongoing beta cell destruction. The presence of ICAb's has preceded the appearance of clinical evidence of IDDM by as long as eight years. The detection of ICAb's in first-degree relatives of individuals with IDDM identifies a population at risk for developing IDDM. Means of intervention need to be established to prevent progressive beta cell destruction in these individuals.


Diabetologia ◽  
1993 ◽  
Vol 36 (7) ◽  
pp. 622-627 ◽  
Author(s):  
S. De Cosmo ◽  
K. Earle ◽  
A. Morocutti ◽  
J. Walker ◽  
P. Ruggenenti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document